Benjamin Besse, Alexander I. Spira, Joel W. Neal, Koichi Goto, Christina S. Baik, Melina E. Marmarelis, Jong-Seok Lee, Zacharias Anastasiou, Joshua C. Curtin, Xuesong Lyu, Janine Mahoney, Levon Demirdjian, Craig S. Meyer, Youyi Zhang, Isabelle Leconte, Patricia Lorenzini, Roland E. Knoblauch, Leonardo Trani, Mahadi Baig, Joshua M. Bauml, Gee-Chen Chang, Byoung Chul Cho, Sophie Cousin, Jiuwei Cui, Giuseppe Curigliano, Gianluca Del Conte, Xiaorong Dong, Enriqueta Felip, Pilar Garrido, Nicolas Girard, Adriano Gravina, Frank Griesinger, Matthew Gubens, Eric Haura, Eiki Ichihara, Dong-Wan Kim, Se Hyun Kim, Se-Hoon Lee, Yongsheng Li, Shun Lu, Melina Marmarelis, Sebastian Michels, Joel Neal, Jorge Nieva, Luis Paz-Ares, Niels Reinmuth, Yuki Sato, Alexander Spira, Meili Sun, Pascale Tomasini, Yongsheng Wang, Marcel Wiesweg, Lin Wu, James Chih-Hsin Yang, Yu Yao, Yiping Zhang, Minglei Zhuo. "Amivantamab Plus Lazertinib in Atypical
                    <i>EGFR</i>
                    -Mutated Advanced Non–Small Cell Lung Cancer: Results From CHRYSALIS-2." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco-24-02835